4//SEC Filing
Furiex Pharmaceuticals, Inc. 4
Accession 0001437749-13-008082
CIK 0001484478operating
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 4:46 PM ET
Size
17.3 KB
Accession
0001437749-13-008082
Insider Transaction Report
Form 4
CORR PETER B
Director
Transactions
- Exercise/Conversion
Common Stock
2013-06-25$9.11/sh+1,000$9,110→ 7,293 total - Exercise/Conversion
Stock Options (to buy)
2013-06-24−3,600→ 13,970 totalExercise: $9.11Exp: 2020-06-17→ Common Stock (3,600 underlying) - Exercise/Conversion
Common Stock
2013-06-24$9.11/sh+3,600$32,796→ 7,180 total - Tax Payment
Common Stock
2013-06-24$33.12/sh−887$29,375→ 6,293 total - Tax Payment
Common Stock
2013-06-25$33.30/sh−400$13,319→ 6,893 total - Exercise/Conversion
Stock Options (to buy)
2013-06-25−1,000→ 12,970 totalExercise: $9.11Exp: 2020-06-17→ Common Stock (1,000 underlying)
Holdings
- 8,675
Stock Options (to buy)
Exercise: $13.94Exp: 2021-05-19→ Common Stock (8,675 underlying) - 17,500
Stock Options (to buy)
Exercise: $18.22Exp: 2022-05-24→ Common Stock (17,500 underlying) - 8,825
Stock Options (to buy)
Exercise: $13.45Exp: 2021-10-12→ Common Stock (8,825 underlying)
Footnotes (4)
- [F1]The options were awarded on 6/17/2010 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
- [F2]The options were awarded on 5/19/2011 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
- [F3]The options were awarded on 10/12/2011 and vest and become exercisable in full on the earlier of 5/19/2012 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
- [F4]The options were awarded on 5/24/2012 and vest and become exercisable in full on the earlier of 5/24/2013 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
Documents
Issuer
Furiex Pharmaceuticals, Inc.
CIK 0001484478
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001484478
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 4:46 PM ET
- Size
- 17.3 KB